- Home
- ABP vs TXMD Comparison
ABP vs TXMD Comparison
Compare ABP & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABP
- TXMD
- Stock Information
- Founded
- ABP 2004
- TXMD 2008
- Country
- ABP United States
- TXMD United States
- Employees
- ABP N/A
- TXMD N/A
- Industry
- ABP Biotechnology: Pharmaceutical Preparations
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- ABP Health Care
- TXMD Health Care
- Exchange
- ABP Nasdaq
- TXMD Nasdaq
- Market Cap
- ABP 15.2M
- TXMD 12.3M
- IPO Year
- ABP N/A
- TXMD N/A
- Fundamental
- Price
- ABP $0.21
- TXMD $1.23
- Analyst Decision
- ABP Hold
- TXMD
- Analyst Count
- ABP 1
- TXMD 0
- Target Price
- ABP N/A
- TXMD N/A
- AVG Volume (30 Days)
- ABP 4.8M
- TXMD 506.6K
- Earning Date
- ABP 11-18-2025
- TXMD 11-12-2025
- Dividend Yield
- ABP N/A
- TXMD N/A
- EPS Growth
- ABP N/A
- TXMD N/A
- EPS
- ABP N/A
- TXMD N/A
- Revenue
- ABP $183,000.00
- TXMD $2,559,000.00
- Revenue This Year
- ABP N/A
- TXMD $427.09
- Revenue Next Year
- ABP N/A
- TXMD N/A
- P/E Ratio
- ABP N/A
- TXMD N/A
- Revenue Growth
- ABP 154.17
- TXMD 156.93
- 52 Week Low
- ABP $0.15
- TXMD $0.70
- 52 Week High
- ABP $11.19
- TXMD $2.44
- Technical
- Relative Strength Index (RSI)
- ABP 49.33
- TXMD 59.44
- Support Level
- ABP $0.19
- TXMD $1.20
- Resistance Level
- ABP $0.21
- TXMD $1.37
- Average True Range (ATR)
- ABP 0.02
- TXMD 0.12
- MACD
- ABP 0.00
- TXMD 0.02
- Stochastic Oscillator
- ABP 59.64
- TXMD 29.85
About ABP Abpro Holdings Inc Common Stock
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.